Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Andrea Rzepiel"'
Autor:
Andrea Rzepiel, Anna Horváth, Nóra Kutszegi, András Gézsi, Judit C. Sági, Laura Almási, Bálint Egyed, Péter Lőrincz, Tamás Visnovitz, Gábor T. Kovács, Csaba Szalai, Ágnes F. Semsei, Dániel J. Erdélyi
Publikováno v:
Molecular and Cellular Probes, Vol 67, Iss , Pp 101893- (2023)
Background: Minimal residual disease (MRD) is one of the most valuable independent prognostic factors in acute lymphoblastic leukemia (ALL). Bone marrow (BM) aspiration, however, is an invasive process. Previous studies have shown that microRNAs (miR
Externí odkaz:
https://doaj.org/article/7887748bf61b40a6857fee81c87f6256
Autor:
Bálint Egyed, Nóra Kutszegi, Judit C. Sági, András Gézsi, Andrea Rzepiel, Tamás Visnovitz, Péter Lőrincz, Judit Müller, Marianna Zombori, Csaba Szalai, Dániel J. Erdélyi, Gábor T. Kovács, Ágnes F. Semsei
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Abstract Background Refractory central nervous system (CNS) involvement is among the major causes of therapy failure in childhood acute leukemia. Applying contemporary diagnostic methods, CNS disease is often underdiagnosed. To explore more sensitive
Externí odkaz:
https://doaj.org/article/7e0411fad4d44a358819f5d941e51baa
Autor:
Andrea Rzepiel, Nóra Kutszegi, András Gézsi, Judit C. Sági, Bálint Egyed, György Péter, Henriett Butz, Gábor Nyírő, Judit Müller, Gábor T. Kovács, Csaba Szalai, Ágnes F. Semsei, Dániel J. Erdélyi
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-16 (2019)
Abstract Background Treatment stratification based on bone marrow minimal residual disease (MRD) at set time points has resulted in considerably improved survival in pediatric acute lymphoblastic leukemia (ALL). Treatment response is assessed using b
Externí odkaz:
https://doaj.org/article/ac8a0bda736340688e1856e1edc3ed4e
Autor:
Judit C. Sági, Bálint Egyed, Andrea Kelemen, Nóra Kutszegi, Márta Hegyi, András Gézsi, Martina Ayaka Herlitschke, Andrea Rzepiel, Lili E. Fodor, Gábor Ottóffy, Gábor T. Kovács, Dániel J. Erdélyi, Csaba Szalai, Ágnes F. Semsei
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background The treatment of acute lymphoblastic leukemia (ALL) and osteosarcoma (OSC) is very effective: the vast majority of patients recover and survive for decades. However, they still need to face serious adverse effects of chemotherapy.
Externí odkaz:
https://doaj.org/article/bb7ab0e3755249b8b06f75269a0b8ea8
Autor:
Csaba Szalai, Péter Lőrincz, Tamás Visnovitz, Bálint Egyed, Judit C. Sági, Judit Müller, Andrea Rzepiel, András Gézsi, Marianna Zombori, Ágnes F. Semsei, Dániel J. Erdélyi, Nóra Kutszegi, Gábor T. Kovács
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Journal of Translational Medicine
Journal of Translational Medicine
Background Refractory central nervous system (CNS) involvement is among the major causes of therapy failure in childhood acute leukemia. Applying contemporary diagnostic methods, CNS disease is often underdiagnosed. To explore more sensitive and less
Autor:
Gábor Nyírő, Gábor T. Kovács, Henriett Butz, Andrea Rzepiel, Nóra Kutszegi, András Gézsi, György Péter, Ágnes F. Semsei, Dániel J. Erdélyi, Bálint Egyed, Judit Müller, Judit C. Sági, Csaba Szalai
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-16 (2019)
Journal of Translational Medicine
Journal of Translational Medicine
Background Treatment stratification based on bone marrow minimal residual disease (MRD) at set time points has resulted in considerably improved survival in pediatric acute lymphoblastic leukemia (ALL). Treatment response is assessed using bone marro
Autor:
Gábor T. Kovács, Dániel J. Erdélyi, Bálint Egyed, Nóra Kutszegi, Márta Hegyi, Gábor Ottóffy, Ágnes F. Semsei, Lili E. Fodor, Andrea Kelemen, Csaba Szalai, András Gézsi, Martina Ayaka Herlitschke, Judit C. Sági, Andrea Rzepiel
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
BMC Cancer
BMC Cancer
Background The treatment of acute lymphoblastic leukemia (ALL) and osteosarcoma (OSC) is very effective: the vast majority of patients recover and survive for decades. However, they still need to face serious adverse effects of chemotherapy. One of t
Autor:
Dániel J. Erdélyi, Judit Müller, Bálint Egyed, Andrea Rzepiel, Nóra Kutszegi, Gabor G. Kovacs, Judit Csányiné Sági, Ágnes F. Semsei
Publikováno v:
Orvosi Hetilap. 159:786-797
Abstract: Owing to clinical trials and improvement over the past few decades, the majority of children with acute lymphoblastic leukemia (ALL) survive by first-line chemotherapy and combat with the problems of returning to community. However, many pa
Autor:
Dániel J. Erdélyi, Andrea Rzepiel, Nóra Kutszegi, Andrea Kelemen, Krisztina Pálóczi, Judit C. Sági, Edit I. Buzás, Ágnes F. Semsei
Publikováno v:
Orvosi Hetilap. 157:1379-1384
Extracellular vesicles are produced in all organisms. The most intensively investigated categories of extracellular vesicles include apoptotic bodies, microvesicles and exosomes. Among a very wide range of areas, their role has been confirmed in inte
Autor:
Dániel J. Erdélyi, Judit C. Sági, Andrea Rzepiel, Csaba Szalai, Bálint Egyed, Andrés Gézsi, Ágnes F. Semsei
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S162
Context Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. Five-year survival rate is nearly 90%. Measurement of minimal residual disease (MRD) at set time points has become a fundamental part of stratified treatment in ALL.